Targeting efficiency of galactosylated liposomes to hepatocytes in vivo: Effect of lipid composition

Pharmaceutical Research

Volumn 19, Issue 12, 2002, Pages 1808-1814

  Murao, Aki ^a   Nishikawa, Makiya ^a   Managit, Chittima ^a   Wong, Joseph ^b   Kawakami, Shigeru ^a   Yamashita, Fumiyoshi ^a   Hashida, Mitsuru ^a  

^a KYOTO UNIVERSITY   (Japan)

^b BAXTER HEALTHCARE CORPORATION   (United States)

Author keywords

Asialoglycoprotein receptor; Drug targeting; Hepatocytes; Internalization; Liposome

Indexed keywords

CHOLESTEN 5 YLOXY N [4 [(1 IMINO 2 DEXTRO THIOGALACTOSYLETHYL)AMINO]BUTYL]FORMAMIDE; CHOLESTEROL DERIVATIVE; CHOLESTEROL HEXADECYL ETHER; DISTEAROYLPHOSPHATIDYLCHOLINE; ETHER DERIVATIVE; FORMAMIDE DERIVATIVE; GALACTOSE; LIPOSOME; TRITIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CELL STRAIN HEPG2; DRUG DISPOSITION; DRUG RECEPTOR BINDING; DRUG TARGETING; DRUG UPTAKE; HUMAN; HUMAN CELL; INTERNALIZATION; LIPID COMPOSITION; LIVER CELL; MALE; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

ANIMALS; DRUG DELIVERY SYSTEMS; HEPATOCYTES; HUMANS; LIPIDS; LIPOSOMES; MALE; MICE; THIOGALACTOSIDES;

EID: 0036909463     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021433206081     Document Type: Article

References (30)

1. G. Ashwell and J. Harford. Carbohydrate-specific receptors of the liver. Annu. Rev. Biochem. 51:531-554 (1982).
2. Y. C. Lee, R. R. Townsend, M. R. Hardy, J. Lönngren, J. Arnarp, M. Haraldsson, and H. Lönn. Binding of synthetic oligosaccharides to the hepatic Gal/GalNAc lectin. Dependence on fine structural features. J. Biol. Chem. 258:199-202 (1983).
3. M. Nishikawa, H. Hirabayashi, Y. Takakura, and M. Hashida. Design for cell-specific targeting of proteins utilizing sugarrecognition mechanism: Effect of molecular weight of proteins on targeting efficiency. Pharm. Res. 12:209-214 (1995).
4. M. Nishikawa, C. Miyazaki, F. Yamashita, Y. Takakura, and M. Hashida. Galactosylated proteins are recognized by the liver according to the surface density of galactose moieties. Am. J. Physiol. 268:G849-G856 (1995).
5. H. Hirabayashi, M. Nishikawa, Y. Takakura, and M. Hashida. Development and pharmacokinetics of galactosylated poly-L-glutamic acid as a biodegradable carrier for liver-specific drug delivery. Pharm. Res. 13:880-884 (1996).
6. T. M. Allen. Long-circulating (sterically stabilized) liposomes for targeted drug delivery. Trends Pharmacol. Sci. 15:215-220 (1994).
7. S. Kawakami, F. Yamashita, M. Nishikawa, Y. Takakura, and M. Hashida. Asialoglycoprotein receptor-mediated gene transfer using novel galactosylated cationic liposomes. Biochem. Biophys. Res. Commun. 252:78-83 (1998).
8. S. Kawakami, S. Fumoto, M. Nishikawa, F. Yamashita, and M. Hashida. In vivo gene delivery to the liver using novel galactosylated cationic liposomes. Pharm. Res. 17:306-313 (2000).
9. 1 to hepatocytes using galactosylated liposomes. J. Drug Target. 8:137-142 (2000).
10. Y. Hattori, S. Kawakami, F. Yamashita, and M. Hashida. Controlled biodistribution of galactosylated liposomes and incorporated probucol in hepatocyte-selective drug targeting. J. Control. Release 69:369-377 (2000).
11. S. Kawakami, C. Munakata, S. Fumoto, F. Yamashita, and M. Hashida. Novel galactosylated liposomes for hepatocyte-selective targeting of lipophilic drugs. J. Pharm. Sci. 90:105-113 (2001).
12. A. Chonn, S. C. Semple, and P. R. Cullis. Association of blood proteins with large unilamellar liposomes in vivo. Relation to circulation lifetimes. J. Biol. Chem. 267:18759-18765 (1992).
13. S. C. Semple, A. Chonn, and P. R. Cullis. Influence of cholesterol on the association of plasma proteins with liposomes. Biochemistry 35:2521-2525 (1996).
14. J. H. Senior. Fate and behavior of liposomes in vivo: A review of controlling factors. Crit. Rev. Ther. Drug Carrier Syst. 3:123-193 (1987).
15. T. Takino, C. Nakajima, Y. Takakura, H. Sezaki, and M. Hashida. Controlled biodistribution of highly lipophilic drugs with various parenteral formulations. J. Drug Target. 1:117-124 (1993).
16. A. G. Morell, R. A. Irvine, I. Sternlieb, I. H. Scheinberg, and G. Ashwell. Physical and chemical studies on ceruloplasmin. V. Metabolic studies on sialic acid-free ceruloplasmin in vivo. J. Biol. Chem. 243:155-159 (1968).
17. D. T. Connolly, R. R. Townsend, K. Kawaguchi, W. R. Bell, and Y. C. Lee. Binding and endocytosis of cluster glycosides by rabbit hepatocytes. Evidence for a short-circuit pathway that does not lead to degradation. J. Biol. Chem. 257:939-945 (1982).
18. Y. C. Lee, R. R. Townsend, M. R. Hardy, J. Lonngren, J. Arnarp, M. Haraldsson, and H. Lonn. Binding of synthetic oligosaccharides to the hepatic Gal/GalNAc lectin. Dependence on fine structural features. J. Biol. Chem. 258:199-202 (1983).
19. R. T. Lee, P. Lin, and Y. C. Lee. New synthetic cluster ligands for galactose/N-acetylgalactosamine-specific lectin of mammalian liver. Biochemistry 23:4255-4261 (1984).
20. H. H. Spanjer, T. J. C. van Berkel, G. L. Scherphof, and H. J. M. Kempen. The effect of a water-soluble tris-galactoside terminated cholesterol derivative on the in vivo fate of small unilamellar vesicles in rats. Biochim. Biophys. Acta 816:396-402 (1985).
21. E. A. Biessen, D. M. Beuting, H. C. Roelen, G. A. van de Marel, J. H. van Boom, and T. J. C. van Berkel. Synthesis of cluster galactosides with high affinity for the hepatic asialoglycoprotein receptor. J. Med. Chem. 38:1538-1546 (1995).
22. S. Kawakami, A. Sato, M. Nishikawa, F. Yamashita, and M. Hashida. Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes. Gene Ther. 7:292-299 (2000).
23. S. Kawakami, J. Wong, A. Sato, Y. Hattori, F. Yamashita, and M. Hashida. Biodistribution characteristics of mannosylated, fucosylated, and galactosylated liposomes in mice. Biochim. Biophys. Acta 1524:258-265 (2000).
24. S. C. Semple, A. Chonn, and P. R. Cullis. Interactions of liposomes and lipid-based carrier systems with blood proteins: Relation to clearance behaviour in vivo. Adv. Drug Deliv. Rev. 32:3-17 (1998).
25. K. Ogawara, M. Nishikawa, Y. Takakura, and M. Hashida. Pharmacokinetic analysis of hepatic uptake of galactosylated bovine serum albumin in a perfused rat liver. J. Control. Release 50:309-317 (1998).
26. 2H nuclear magnetic resonance and differential scanning calorimetry. Biochemistry 29:451-464 (1990).
27. 2H nuclear magnetic resonance study of phosphatidylcholine/cholesterol interactions: Characterization of liquid-gel phases. Biochemistry 32:13277-13287 (1993).
28. C. A. Hunt. Related Articles Liposomes disposition in vivo. V. Liposome stability in plasma and implications for drug carrier function. Biochim. Biophys. Acta 719:450-463 (1982).
29. V. A. Slepushkin, A. I. Starov, A. G. Bukrinskaya, A. B. Imbs, M. A. Martynova, L. S. Kogtev, E. L. Vodovozova, N. G. Timofeeva, J. G. Molotkovsky, and L. D. Bergelson. Interaction of influenza virus with gangliosides and liposomes containing gangliosides. Eur. J. Biochem. 173:599-605 (1988).
30. A. A. Yaroslavov, A. A. Efimova, V. I. Lobyshev, Y. A. Ermakov, and V. A. Kabanov. Reversibility of structural rearrangements in lipid membranes induced by adsorption-desorption of a polycation. Membr. Cell Biol. 10:683-688 (1997).